Page last updated: 2024-12-06

3-hydroxy-4'-nitro-2-naphthanilide chloroacetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID67273
SCHEMBL ID1344307
MeSH IDM0159072

Synonyms (80)

Synonym
EU-0067019
HMS1473D13
c.i. developer 21
2-naphtho-o-toluidide, 3-hydroxy-
135-61-5
azoground d
c.i. azoic coupling component 110
naphtanilide d
c.i. azoic coupling component 18
azoic coupling component 18
dianix developer nd
mitsui naphthozol d
1-(2',3'-hydroxynaphthoylamino)-2-methylbenzene
naftolo md
2-naphthalenecarboxamide, 3-hydroxy-n-(2-methylphenyl)-
naphthol as-d dispersible
anthonaphthol as-d
dragonthol d
naphtoelan d
naphthol as-d supra
naphtanilide d supra
miketazol developer ndf
hiltonaphthol as-d
ultrazol d
azonaphtol ot
naphthoide ad
acco naf-sol as-d
acna naphthol e
c.i. 37520
naphthanil as-d
naphthol as d
cibanaphthol rto
nsc37188
brenthol ot
amanil naphthol as-d
naphtazol d
amarthol as-d
celcot rto
brentosyn otn
nsc-37188
azotol ot
naphtol as-d
daito grounder d
solunaptol ot
naphthol as-d
acco naphthol as-d
naphtol as-d supra
diathol d
tulathol as-d
OPREA1_623285
IDI1_019397
CHEMDIV3_000079
3-hydroxy-4'-nitro-2-naphthanilide chloroacetate
nsc 37188
naphthol as-d (van)
3-hydroxy-2'-methyl-2-naphthanilide
einecs 205-205-0
3-hydroxy-n-(2-methylphenyl)naphthalene-2-carboxamide
3-hydroxy-n-(2-methylphenyl)-2-naphthamide
FT-0659231
2-hydroxy-3-naphthoic acid o-toluidide
3-hydroxy-n-(o-tolyl)-2-naphthamide
H0315
AKOS000121439
3-hydroxy-n-o-tolylnaphthalene-2-carboxamide
ec 205-205-0
BP-13372
SCHEMBL1344307
DTXSID6059653
naphthol-as-d
FBLAHUMENIHUGG-UHFFFAOYSA-N
3-hydroxy-n-(2-methylphenyl)-2-naphthamide #
sr-01000391140
SR-01000391140-1
mfcd00021634
2-hydroxy-3-naphthoyl-o-toluidine
CS-0204505
EN300-21570
D90836
BS-23119
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (40.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.36

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.36 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.16 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.36)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]